ReviewPublic health weekly report2026
The Tuberculosis Relief Belt Project in the Republic of Korea: A 10-Year Review of Performance and Future Directions (2014-2024).
Review in Public health weekly report, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: This study evaluates the effectiveness and efficiency of the Tuberculosis (TB) Relief Belt Project (2014-2024) and proposes sustainable operational strategies by reviewing its role as a public health safety net and its policy impact. Methods: The project's implementation status, beneficiary characteristics, support case numbers, and institutional improvements were analyzed using annual reports, institutional performance data, policy research reports, and relevant academic literature from 2014 to 2024. Results: The TB Relief Belt Project expanded from four participating institutions in 2014 to 17 by 2024. During this expansion, the project consistently provided comprehensive, integrated services to vulnerable patients with TB, including medical expenses coverage, caregiving costs, transportation fees, nutritional support, and referral treatment costs. Notably, the number of cases receiving medical expense support increased substantially, from 31 in 2014 to 589 in 2024. Conclusions: Although the overall prevalence of TB is declining, vulnerable patients requiring support through the TB Relief Belt Project has continued to rise in number. This trend is attributable to the growth of economically disadvantaged populations, intensified outreach projects since 2019, and the expansion of eligibility for medical expense support following the introduction of the TB patient vulnerability assessment in 2022. Future efforts should focus on enhancing the project's sustainability and effectiveness by expanding into nonparticipating regions, strengthening engagement at existing institutions, and increasing project publicity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.